Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Adverum Biotechnologies, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 78 | 2 | 59 | −17 |
| Shares | 58.5M | 16.9K | 57.3M | −1.20M (−2.1%) |
| Value | $55.6M | $16.1K | $33.2M | −$22.4M (−40.3%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 7,067,179 | $4.10M | 3.91% |
| Sonic GP LLC | 4,552,068 | $2.64M | 1.98% |
| Acadian Asset Management LLC | 129,212 | $74.0K | 0.00% |
| CM Management, LLC | 100,000 | $58.0K | 0.07% |
| Virtu Financial LLC | 17,174 | $10.0K | 0.00% |
| Susquehanna International Group, LLP | 12,606 | $7.30K | 0.00% |
| Mariner, LLC | 10,000 | $6.00K | 0.00% |
Sold out (24)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (2)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Pinz Capital Management, LP | 15,700 | $15.0K |
| American Portfolios Advisors | 1,150 | $1.09K |